Published On: Fri, Sep 5th, 2014

Organovo Holdings Inc. (NYSEMKT:ONVO): Invited for the Global Healthcare Conference

On September 05, 2014, Organovo Holdings Inc. (NYSEMKT:ONVO) which is a three-dimensional biology company with main focus on providing advance 3D bio-printing technology, announced that it has been invited at the Morgan Stanley Global Healthcare Conference, which is scheduled to be held from September 8, 2014 to September 10, 2014 at The Grand Hyatt Hotel, New York. Organovo Holdings Inc. (NYSEMKT:ONVO)’s CEO and Chairman, Mr. Keith Murphy will present at 9:20 a.m. on September 8, 2014.

Company Brief:

Organovo Holdings Inc. (NYSEMKT:ONVO) is engaged in designing and creating functional, three-dimensional human tissues which is useful for therapeutic applications and medical research. The Company is working in partnership with academic and pharmaceutical partners for the development of human biological disease models in three dimensions. These 3D human tissues have the potential to increase the drug discovery process, allowing treatments to be developed at lower cost and faster. In addition to number of scientific publications, the technology of the company has been featured in Time Magazine, The Wall Street Journal, and The Economist, and numerous others. The company is trying to change the shape of medical practice and research.

Management Team:

The company’s management team is well prepared to change the shape of medical research. Mr. Keith Murphy is a Chairman and Chief Executive Officer of the company. Mr. Barry Michaels is a Corporate Secretary and Chief Financial Officer. Ms. Sharon Collins Presnell, Ph.D. is a Chief Technology Officer and Executive Vice President of Research & Development. Mr. Eric Michael David, M.D., J.D. is a Chief Strategy Officer. Mr. Michael Renard is Executive Vice President of Commercial Operations.

Mr. Keith Murphy is a co-founder of the company and is responsible for company’s all operations since 2007. He is having experience of more than 20 years in biotechnology, including Director of Process Development roles and serving in Product Strategy at Amgen.

© Copyright 2016 OTC News Magazine. All rights reserved.